Brief: Exicure Announces Termination Of Abbvie And Ipsen Collaboration Agreements

Exicure

14/12/2022 10:03

Dec 14 (Reuters) - Exicure Inc  XCUR.O :
    * EXICURE, INC. ANNOUNCES TERMINATION OF ABBVIE AND IPSEN
COLLABORATION AGREEMENTS
    * EXICURE AND ABBVIE HAVE TERMINATED THEIR AGREEMENT
RELATING TO
DEVELOPMENT PROGRAMS TARGETING HAIR LOSS DISORDERS
    * EXICURE AND IPSEN HAVE TERMINATED THEIR AGREEMENT RELATING
TO
DEVELOPMENT PROGRAMS TARGETING ANGELMAN SYNDROME AND
HUNTINGTON'S DISEASE
    * REGAINS ABILITY TO INDEPENDENTLY DEVELOP MEDICINES
TARGETING
HAIR LOSS DISORDERS, ANGELMAN SYNDROME, AND HUNTINGTON'S DISEASE
    * IPSEN RETAINS RIGHT TO RE-ENTER INTO COLLABORATION WITH
EXICURE
IN HUNTINGTON'S DISEASE AND ANGELMAN'S SYNDROME

Source text for Eikon:  ID:nBw6wXrpna 
Further company coverage:  XCUR.O 
 ((Reuters.Briefs@thomsonreuters.com;))